Search results for "Vaccination."

showing 10 items of 654 documents

A Hybrid Expressing Genetically Engineered Major Allergens of the <i>Parietaria</i> Pollen as a Tool for Specific Allergy Vaccination

2006

<i>Background:</i> Allergy is an immunological disorder affecting about 25% of the population living in the industrialized countries. Specific immunotherapy is the only treatment with a long-lasting relief of allergic symptoms and able to reduce the risk of developing new allergic sensitizations and inhibiting the development of clinical asthma in children treated for allergic rhinitis. <i>Methods:</i> By means of DNA recombinant technology, we were able to design a head to tail dimer expressing disulphide bond variants of the major allergen of the <i>Parietaria </i>pollen. IgE binding activity was studied by Western blot, ELISA inhibition assays and the …

Allergyeducation.field_of_studyParietariabiologyGenetically engineeredImmunologyPopulationSpecific immunotherapyGeneral Medicinebiology.organism_classificationmedicine.disease_causemedicine.diseaseVaccinationAllergenPollenImmunologymedicineImmunology and AllergyeducationInternational Archives of Allergy and Immunology
researchProduct

Antibody Induction Directed against the Tumor-Associated MUC4 Glycoprotein

2015

Mucin glycoproteins are important diagnostic and therapeutic targets for cancer treatment. Although several strategies have been developed to explore anti-tumor vaccines based on MUC1 glycopeptides, only few studies have focused on vaccines directed against the tumor-associated MUC4 glycoprotein. MUC4 is an important tumor marker overexpressed in lung cancer and uniquely expressed in pancreatic ductual adenocarcinoma. The aberrant glycosylation of MUC4 in tumor cells results in an exposure of its peptide backbone and the formation of tumor-associated glycopeptide antigens. Due to the low immunogenicity of these endogenous structures, their conjugation with immune stimulating peptide or prot…

Antibodies NeoplasmMolecular Sequence DataCancer VaccinesBiochemistryEpitopeEpitopesMiceAntigenAntibody SpecificityCell Line TumorTetanus ToxoidAnimalsHumansAmino Acid SequenceMolecular BiologyMUC1chemistry.chemical_classificationMice Inbred BALB CMucin-4biologyImmune SeraImmunogenicityVaccinationOrganic ChemistryToxoidGlycopeptidePancreatic NeoplasmschemistryTandem Repeat SequencesImmunologybiology.proteinMolecular MedicineFemalesense organsAntibodyGlycoproteinChemBioChem
researchProduct

Maturation of IgG avidity to individual rubella virus structural proteins.

2001

Background: the structural proteins of rubella virus, the capsid protein C and the envelope glycoproteins E1 and E2 were produced in lepidopteran insect cells using baculovirus expression vectors. The C-terminal ends of the corresponding proteins were fused to a polyhistidine tag for easy and gentle purification by metal ion affinity chromatography. Objectives: to investigate the maturation of natural and vaccinal IgG avidity against individual authentic and recombinant rubella virus (RV) structural proteins. Study design the analysis was carried out using a modified immunoblotting technique where the purified baculovirus-expressed proteins were compared with authentic rubella virus protein…

Antibody Affinitymedicine.disease_causeAntibodies ViralVirusbaculovirusViral envelopeViral Envelope ProteinsavidityVirologyImmunoblot AnalysisexpressionmedicineHumansAvidityRubella VaccineRubellachemistry.chemical_classificationbiologyViral Core ProteinsVaccinationstructural proteinsRubella virusbiology.organism_classificationVirologyInfectious DiseasesCapsidchemistryImmunoglobulin GTogaviridaeGlycoproteinrubella virusRubella virusJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
researchProduct

Immuntherapie des Kolorektalkarzinoms - aktueller Stand und Perspektiven

2006

The specific immunotherapy of colorectal cancer initially revealed promising results. However, a significant clinical benefit for patients has still to be proven in phase III trails. In order to compare the different clinical approaches and early phase I - II studies, there is an urgent need for the establishment and acceptance of new standardized diagnostic tools for detecting and quantifying induced and clinical relevant immune responses in patients. Whether or not subgroups with a certain genetic background, such as specific HLA alleles, reveal a better benefit from tumour vaccinations needs to be further analysed. Currently, only two specific antibodies, targeting membraneous receptors …

Antibody-dependent cell-mediated cytotoxicitybiologyColorectal cancerbusiness.industrymedicine.medical_treatmentGastroenterologyHuman leukocyte antigenImmunotherapymedicine.diseaseClinical trialVaccinationImmune systemImmunologymedicinebiology.proteinAntibodybusinessZeitschrift für Gastroenterologie
researchProduct

Targeting p53, hdm2, and CD19: vaccination and immunologic strategies.

2000

Peptides presented by class I major histocompatibility complex (MHC) molecules and derived from normal self-proteins that are expressed at elevated levels by cells from a variety of human (Hu) malignancies provide, in theory, potential target antigens for a broad-spectrum, cytotoxic T lymphocyte (CTL)-based immunotherapy of cancer and hematologic malignancies. However, as such tumor- and leukemia-associated self-proteins are also expressed at low levels in some types of normal tissues, such as thymus, spleen and lymphohemopoietic cells, these self-MHC-self-peptide complexes may also represent thymic and/or peripheral tolerogens, thereby preventing immune responses. This is particularly true…

Antigen presentationAntigens CD19chemical and pharmacologic phenomenaMice TransgenicMajor histocompatibility complexEpitopeMiceImmune systemAntigenNeoplasmsProto-Oncogene ProteinsCytotoxic T cellAnimalsHumansAvidityTransplantationAntigen PresentationbiologyHistocompatibility Antigens Class IVaccinationNuclear ProteinsProto-Oncogene Proteins c-mdm2HematologyCTL*Immunologybiology.proteinTumor Suppressor Protein p53T-Lymphocytes CytotoxicBone marrow transplantation
researchProduct

Modeling Chickenpox Dynamics with a Discrete Time Bayesian Stochastic Compartmental Model

2018

[EN] We present a Bayesian stochastic susceptible-exposed-infectious-recovered model in discrete time to understand chickenpox transmission in the Valencian Community, Spain. During the last decades, different strategies have been introduced in the routine immunization program in order to reduce the impact of this disease, which remains a public health's great concern. Under this scenario, a model capable of explaining closely the dynamics of chickenpox under the different vaccination strategies is of utter importance to assess their effectiveness. The proposed model takes into account both heterogeneous mixing of individuals in the population and the inherent stochasticity in the transmiss…

Article SubjectGeneral Computer ScienceComputer scienceComputationBayesian probabilityPosterior probabilityPopulation01 natural scienceslcsh:QA75.5-76.95010305 fluids & plasmas010104 statistics & probabilityMixing (mathematics)0103 physical sciencesmedicineEconometrics0101 mathematicseducationeducation.field_of_studyMultidisciplinaryChickenpoxPrediction intervalmedicine.diseaseVaccinationDiscrete time and continuous timePosterior predictive distributionlcsh:Electronic computers. Computer scienceMATEMATICA APLICADA
researchProduct

Psychometric properties and measurement invariance of the Vaccination Attitudes Examination Scale (VAX) in a Spanish sample.

2022

AbstractIn these times of pandemic, the acceptance or rejection of vaccines has become increasingly clear, with a considerable rise in the anti-vaccine movement in Spain. It is important to understand the attitudes that lead a person to refuse vaccination in order to develop more effective public health campaigns. The objective of this study has been to study the psychometric properties and measurement invariance of the Vaccination Attitudes Examination (VAX) scale in a Spanish sample. Confirmatory factor analysis and structural equation modelling have been used to study the psychometric properties of the VAX. Likewise, the measurement invariance by gender and educational level has been stu…

AttitudePsychometricsVaccinationHumansReproducibility of ResultsGeneral MedicinePsicometriaFactor Analysis StatisticalGeneral PsychologyBMC psychology
researchProduct

Attitudes, behaviours and perceptions of Italian General Practitioner trainees towards influenza vaccination in Western Sicily (Italy)

2012

Background: General practitioners (GPs) have to be considered as key figures of health promotion among health care workers since they are strongly asked to recommend influenza vaccination to their patients and perform on them. Despite this consideration, GPs have influenza vaccination rates that are significantly below the 75% coverage proposed by International Public Health guidelines. In order to increase future coverage of influenza vaccination within GPs, and through them within the population, the aim of this study was to assess determinants associated with influenza vaccine uptake among GP trainees. Methods: A survey was carried out on GP trainees attending the training course in Comm…

AttitudesWestern Sicilylcsh:Public aspects of medicinelcsh:ReducationDOAJ:Public Healthlcsh:MedicineGeneral Practitioner Traineeslcsh:RA1-1270Influenza Vaccination General Practitioner Trainees Attitudes Western SicilyDOAJ:Health SciencesInfluenza vaccination; General Practitioner Trainees; Attitudes;Western SicilyInfluenza vaccinationItalian Journal of Public Health
researchProduct

Mechanisms of resistance to autoimmune disease induced by T-cell vaccination.

1991

Many human autoimmune diseases tend to progress slowly. Phases of rapid progression may come to a halt and may be followed by transient or even permanent remissions. Autoimmune diseases in animals either arise spontaneously or are induced. The former tend to be slowly progressive, the latter mostly acute to subacute, and usually followed by spontaneous remissions. The mechanisms at work that prevent rapid disease progression and can effect remissions are poorly understood, but they may provide us with a clue both to natural self-tolerance and to the therapeutic induction of self-tolerance.

Autoimmune diseaseEncephalomyelitis Autoimmune Experimentalbusiness.industrymedicine.medical_treatmentEncephalomyelitisT-LymphocytesImmunologyExperimental autoimmune encephalomyelitisT-cell vaccinationImmunization PassiveImmunotherapymedicine.diseaseImmune toleranceAutoimmune DiseasesVaccinationImmunoglobulin IdiotypesImmunopathologyImmunologymedicineImmune ToleranceImmunology and AllergyAnimalsbusinessAutoimmunity
researchProduct

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022

2022

Background The SARS-CoV-2 variant of concern Omicron was first detected in Italy in November 2021. Aim To comprehensively describe Omicron spread in Italy in the 2 subsequent months and its impact on the overall SARS-CoV-2 circulation at population level. Methods We analyse data from four genomic surveys conducted across the country between December 2021 and January 2022. Combining genomic sequencing results with epidemiological records collated by the National Integrated Surveillance System, the Omicron reproductive number and exponential growth rate are estimated, as well as SARS-CoV-2 transmissibility. Results Omicron became dominant in Italy less than 1 month after its first detection,…

Base SequenceSARS-CoV-2EpidemiologyCOVID–19 SARS–COV–2 DOUBLING TIME GENOMIC SURVEY OMICRON PREVALENCEprevalenceVaccinationPublic Health Environmental and Occupational HealthCOVID-19doubling timeomicronSettore MED/42 - Igiene Generale E Applicatagenomic surveyVirologySARS–CoV–2COVID–19HumansEurosurveillance
researchProduct